WATANABE TODD sold 0.6% of their position (4.38K shares) of ARCUTIS BIOTHERAPEUTICS, INC. on the open market
Open‑market sale worth $114.3K — a minor trim. Review remaining holdings and any 10b5‑1 plan disclosures.
S · 1 sale
Filed: 8/6/2026ACC: 0001628280-26-053753
Director
Since Jan 2020
-4.38K
Net shares
Net seller
$114.3K
Total sold
1
Open market trades
0B · 1S
1
Total transactions
4.38K disposed
Non-Derivative Transactions1
Common Stock
Direct
Shares
−4.38K
Price / share
$26.12
Trade value
$114.26K
% of position
0.6%
8/3/2026
721.58K→717.20K
Total
Net shares
−4.38K
Net value
-$114.26K
| Security | Date | Type | Shares | Price / Share | Trade Value | % of Position | Held Before | Held After |
|---|---|---|---|---|---|---|---|---|
| Common Stock Direct | 8/3/2026 | S · Sale | −4.38K | $26.12 | $114.26K | 0.6% | 721.58K | 717.20K |
| Total | −4.38K | -$114.26K | ||||||
Derivative Transactions0
No derivative transactions reported
Non-Derivative Holdings (Post-Transaction)4
Common Stock
IndirectShares owned25.41K
Common Stock
IndirectShares owned25.41K
Common Stock
IndirectShares owned124.96K
Common Stock
IndirectShares owned57.36K
Total
233.13K indirect233.13K
| Security Title | Shares Owned | Ownership Type |
|---|---|---|
| Common Stock | 25.41K | Indirect |
| Common Stock | 25.41K | Indirect |
| Common Stock | 124.96K | Indirect |
| Common Stock | 57.36K | Indirect |
| Total | 233.13K | 233.13K indirect |
Derivative Holdings (Post-Transaction)0
No derivative holdings reported